Form 4: Elevance Health CAO & Controller Reports Transactions in Company Stock

Ronald W. Penczek, CAO & Controller of Elevance Health, reports acquisition and disposal of company stock and stock options.

Summary

• Ronald W. Penczek, CAO & Controller of Elevance Health, filed a Form 4 detailing changes in beneficial ownership of company stock.
• On March 3, 2025, Penczek disposed of 198 shares of common stock to cover tax liabilities related to vesting restricted stock at a price of $395.5.
• On the same date, Penczek acquired 285 restricted share units and 421 performance-based restricted share units.
• Penczek also acquired an option to purchase 1,081 shares of common stock at a price of $395.5, exercisable in three annual installments starting March 3, 2026.
• Following these transactions, Penczek directly owns 2,290 shares of Elevance Health common stock and an option to purchase 1,081 shares.
• The balance includes shares acquired through a dividend reinvestment plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing primarily reflects routine transactions related to executive compensation. The acquisition of shares and options is a positive sign, but the disposal of shares for tax purposes is a neutral event.

Positives

• The acquisition of restricted share units and performance-based restricted share units indicates confidence in the company's future performance.
• The granting of stock options aligns management's interests with those of shareholders.

Future Outlook

The vesting schedule of the restricted share units extends to 2028, and the stock options are exercisable starting in 2026, indicating a long-term incentive structure.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies. This filing indicates the transactions of a key executive at Elevance Health.

Comparison to Industry Standards

• Stock option grants and restricted stock units are common forms of executive compensation in publicly traded companies, including Elevance Health's peers such as UnitedHealth Group (UNH) and CVS Health (CVS).
• The vesting schedules and exercise prices are generally aligned with industry practices to incentivize long-term performance and shareholder value creation.
• The amounts of shares and options granted are within the typical range for executives at similar levels in comparable companies.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly diluting the share base as options are exercised and restricted stock vests.
• Employees may be impacted through the company's compensation policies and equity-based incentive programs.

Key Dates